Alteration in the expression of MGMT and RUNX3 due to non-CpG promoter methylation and their correlation with different risk factors in esophageal cancer patients

Promoter methylation reflects in the inactivation of different genes like O6-methylguanine-DNA methyltransferase DNA repair gene and runt-related transcription factor 3, a known tumor suppressor gene in various cancers such as esophageal cancer. The promoter methylation was evaluated for O6-methylguanine-DNA methyltransferase and runt-related transcription factor 3 in CpG, CHH, and CHG context (where H is A, T, or C) by next-generation sequencing. The methylation status was correlated with quantitative messenger RNA expression. In addition, messenger RNA expression was correlated with different risk factors like tobacco, alcohol, betel nut consumption, and smoking habit. CpG methylation of O6-methylguanine-DNA methyltransferase promoter had a positive association in the development of esophageal cancer (p < 0.05), whereas runt-related transcription factor 3 promoter methylation showed no significant association (p = 1.0) to develop esophageal cancer. However, the non-CpG methylation, CHH, and CHG were significantly correlated with O6-methylguanine-DNA methyltransferase (p < 0.05) and runt-related transcription factor 3 (p < 0.05) promoters in the development of esophageal cancer. The number of cytosine converted to thymine (C→T) in O6-methylguanine-DNA methyltransferase promoter showed a significant correlation between cases and controls (p < 0.05), but in runt-related transcription factor 3 no such significant correlation was observed. Besides, messenger RNA expression was found to be significantly correlated with promoter hypermethylation of O6-methylguanine-DNA methyltransferase and runt-related transcription factor 3 in the context of CHG and CHH (p < 0.05). The CpG hypermethylation in O6-methylguanine-DNA methyltransferase showed positive (p < 0.05) association, whereas in runt-related transcription factor 3, it showed contrasting negative association (p = 0.23) with their messenger RNA expression. Tobacco, betel nut consumption, and smoking habits were associated with altered messenger RNA expression of O6-methylguanine-DNA methyltransferase (p < 0.05) and betel nut consumption and smoking habits were associated with runt-related transcription factor 3 (p < 0.05). There was no significant association between messenger RNA expression of O6-methylguanine-DNA methyltransferase and runt-related transcription factor 3 with alcohol consumption (p = 0.32 and p = 0.15). In conclusion, our results suggest that an aberrant messenger RNA expression may be the outcome of CpG, CHG, and CHH methylation in O6-methylguanine-DNA methyltransferase, whereas outcome of CHG and CHH methylation in runt-related transcription factor 3 promoters along with risk factors such as consumption of tobacco, betel nut, and smoking habits in esophageal cancer from Northeast India.

[1]  N. Hattori,et al.  Non-CpG methylation occurs in the regulatory region of the Sry gene. , 2011, The Journal of reproduction and development.

[2]  Y. Wong,et al.  Hypermethylation of MGMT and DAPK gene promoters is associated with tumorigenesis and metastasis in oral squamous cell carcinoma , 2011 .

[3]  Il-Jin Kim,et al.  Promoter hypermethylation downregulates RUNX3 gene expression in colorectal cancer cell lines , 2004, Oncogene.

[4]  Li-dong Wang,et al.  Promoter hypermethylation and inactivation of O(6)-methylguanine-DNA methyltransferase in esophageal squamous cell carcinomas and its reactivation in cell lines. , 2005, International journal of oncology.

[5]  A. Camargo,et al.  Correlation of MGMT promoter methylation status with gene and protein expression levels in glioblastoma , 2011, Clinics.

[6]  H. Bartsch,et al.  Alert for an epidemic of oral cancer due to use of the betel quid substitutes gutkha and pan masala: a review of agents and causative mechanisms. , 2004, Mutagenesis.

[7]  B. Goh,et al.  Analyses of promoter hypermethylation for RUNX3 and other tumor suppressor genes in nasopharyngeal carcinoma. , 2006, Anticancer research.

[8]  Feng Wu,et al.  The clinicopathological significance of RUNX3 hypermethylation and mRNA expression in human breast cancer, a meta-analysis , 2016, OncoTargets and therapy.

[9]  J. Mahanta,et al.  Betel nut and tobacco chewing; potential risk factors of cancer of oesophagus in Assam, India , 2001, British Journal of Cancer.

[10]  W. H. Kim,et al.  Inactivation of O6-methylguanine-DNA methyltransferase by promoter CpG island hypermethylation in gastric cancers , 2002, British Journal of Cancer.

[11]  M. Calasanz,et al.  Methylation of CpG dinucleotides and/or CCWGG motifs at the promoter of TP53 correlates with decreased gene expression in a subset of acute lymphoblastic leukemia patients , 2003, Oncogene.

[12]  H. Lieberman,et al.  DNA Damage Response Genes and the Development of Cancer Metastasis , 2014, Radiation research.

[13]  Shiqian Zhang,et al.  RUNX3 gene methylation in epithelial ovarian cancer tissues and ovarian cancer cell lines. , 2009, Omics : a journal of integrative biology.

[14]  A. Padhani,et al.  A multicentre phase II trial of primary chemotherapy with cisplatin and protracted venous infusion 5-fluorouracil followed by chemoradiation in patients with carcinoma of the oesophagus. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[15]  B. Saikia,et al.  Promoter methylation of MGMT gene in serum of patients with esophageal squamous cell carcinoma in North East India. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[16]  V. Leelakrishnan,et al.  Runt-Related Transcription Factor 3: Single Nucleotide Polymorphism rs760805, Gene Expression, and Methylation Status in Helicobacter pylori-Infected Patients for Determination of Gastric Cancer Risk , 2013, Journal of Gastrointestinal Cancer.

[17]  D. Pearson,et al.  A distinct region of the MGMT CpG island critical for transcriptional regulation is preferentially methylated in glioblastoma cells and xenografts , 2011, Acta Neuropathologica.

[18]  Yi-peng Tao,et al.  Association of Promoter Methylation of RUNX3 Gene with the Development of Esophageal Cancer: A Meta Analysis , 2014, PloS one.

[19]  Hong-yu Li,et al.  Abnormal MGMT promoter methylation may contribute to the risk of esophageal cancer: a meta-analysis of cohort studies , 2014, Tumor Biology.

[20]  S. Artan,et al.  IDH1 mutations is prognostic marker for primary glioblastoma multiforme but MGMT hypermethylation is not prognostic for primary glioblastoma multiforme. , 2015, Gene.

[21]  S. Dayanandan,et al.  Genetic structure and diversity of indigenous rice (Oryza sativa) varieties in the Eastern Himalayan region of Northeast India , 2013, SpringerPlus.

[22]  Lina Wang,et al.  The association between runt-related transcription factor 3 gene promoter methylation and gastric cancer: A meta-analysis. , 2016, Journal of cancer research and therapeutics.

[23]  R. Mehrotra,et al.  GSTM1 and GSTT1 polymorphism and susceptibility to esophageal cancer in high- and low-risk regions of India , 2013, Tumor Biology.

[24]  S. Bae,et al.  Tumor suppressor activity of RUNX3 , 2004, Oncogene.

[25]  J. Zierath,et al.  Evidence for non-CpG methylation in mammals. , 2011, Experimental cell research.

[26]  Lee E. Edsall,et al.  Human DNA methylomes at base resolution show widespread epigenomic differences , 2009, Nature.

[27]  Felix Krueger,et al.  Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications , 2011, Bioinform..

[28]  A. Jeltsch,et al.  The Application of Next Generation Sequencing in DNA Methylation Analysis , 2010, Genes.

[29]  M. Esteller.  Epigenetic gene silencing in cancer: the DNA hypermethylome. , 2007, Human molecular genetics.

[30]  Esley Heizer,et al.  Next‐generation sequencing approach to epigenetic‐based tissue source attribution , 2014, Electrophoresis.

[31]  W. Richards,et al.  RUNX3 inhibits cell proliferation and induces apoptosis by reinstating transforming growth factor beta responsiveness in esophageal adenocarcinoma cells. , 2004, Surgery.

[32]  Mingzhou Guo,et al.  The clinical value of aberrant epigenetic changes of DNA damage repair genes in human cancer , 2016, Oncotarget.

[33]  Hoguen Kim,et al.  Transcriptional silencing of the RUNX3 gene by CpG hypermethylation is associated with lung cancer. , 2004, Biochemical and biophysical research communications.

[34]  F. Antequera,et al.  Structure, function and evolution of CpG island promoters , 2003, Cellular and Molecular Life Sciences CMLS.

[35]  M. Herranz,et al.  The contrasting epigenetic role of RUNX3 when compared with that of MGMT and TIMP3 in glioblastoma multiforme clinical outcomes , 2014, Journal of the Neurological Sciences.

[36]  J. Mahanta,et al.  Gene expression profile of esophageal cancer in North East India by cDNA microarray analysis. , 2007, World journal of gastroenterology.

[37]  M. Hashemi,et al.  Promoter hypermethylation and expression profile of MGMT and CDH1 genes in oral cavity cancer. , 2010, Archives of oral biology.

[38]  M. Salto‐Tellez,et al.  RUNX3 Inactivation in Colorectal Polyps Arising Through Different Pathways of Colonic Carcinogenesis , 2009, The American Journal of Gastroenterology.

[39]  Simone Kreth,et al.  O6-Methylguanine-DNA Methyltransferase (MGMT) mRNA Expression Predicts Outcome in Malignant Glioma Independent of MGMT Promoter Methylation , 2011, PloS one.

[40]  Atsushi Imai,et al.  Prognostic value of aberrant promoter hypermethylation of tumor-related genes in early-stage head and neck cancer , 2016, Oncotarget.

[41]  W. Park,et al.  Hypermethylation of the RUNX3 gene in hepatocellular carcinoma , 2005, Experimental & Molecular Medicine.

[42]  R. Martínez,et al.  Epigenetic Aberrations in Malignant Gliomas: An Open Door Leading to Better Understanding and Treatment , 2007, Epigenetics.

[43]  Kazuhiro Yoshida,et al.  Frequent Loss of RUNX3 Expression by Promoter Hypermethylation in Gastric Carcinoma , 2004, Pathobiology.

[44]  V. Gajalakshmi,et al.  An Independent Survey to Assess Completeness of Registration: Population Based Cancer Registry, Chennai, India. , 2001, Asian Pacific journal of cancer prevention : APJCP.

[45]  S. Gerson.  MGMT: its role in cancer aetiology and cancer therapeutics , 2004, Nature Reviews Cancer.

[46]  J. Nishikawa,et al.  Most methylation-susceptible DNA sequences in human embryonic stem cells undergo a change in conformation or flexibility upon methylation. , 2013, Biochemistry.

[47]  S. Spechler,et al.  Esophageal adenocarcinoma arising in Barrett esophagus. , 2009, Cancer letters.